Key Benefits of IV Ketamine Therapy for Treatment-Resistant Depression at Healing and Psychiatry in Flagstaff, AZ
For individuals living with treatment-resistant depression, traditional antidepressants and conventional therapies sometimes fall short. When standard medications have not provided adequate relief, many patients and their providers begin researching advanced treatment options – and an efficacy comparison of Spravato vs. IV Ketamine for depression often becomes a central part of that conversation. At Healing and Psychiatry in Flagstaff, AZ, IV Ketamine therapy is offered as a clinically supervised option that may provide meaningful benefits for those who have struggled with persistent depressive symptoms. This post explores what IV Ketamine therapy is, who it may help, and the distinct advantages it offers for patients in the Flagstaff community and throughout Northern Arizona.
What Is Treatment-Resistant Depression?
Treatment-resistant depression (TRD) is generally defined as major depressive disorder that has not responded adequately to two or more trials of antidepressant medication at appropriate doses and durations. As of 2026, research suggests that roughly 30% of individuals diagnosed with major depressive disorder may experience some degree of treatment resistance. For these patients, the emotional and functional toll can be significant – affecting work, relationships, daily activities, and overall quality of life.
Because TRD does not respond well to first-line treatments alone, clinicians have increasingly turned to novel interventions that work through different neurological pathways. Among the most studied of these interventions are IV Ketamine and Spravato (esketamine nasal spray), both of which act on the brain’s glutamate system rather than the serotonin and norepinephrine pathways targeted by traditional antidepressants.
How IV Ketamine Therapy Works
Ketamine was originally developed as an anesthetic and has been used in medical settings for decades. In sub-anesthetic doses, however, ketamine has been shown to interact with NMDA receptors in the brain, which may promote the release of glutamate and stimulate the growth of new synaptic connections. This mechanism, often described as neuroplasticity, is believed to be one reason why many patients report improvements in mood and cognitive clarity following IV Ketamine infusions.
Rapid Onset of Action
One of the most widely discussed advantages of IV Ketamine is the speed at which patients may begin to notice changes. Unlike oral antidepressants, which can take four to six weeks to reach full therapeutic effect, IV Ketamine has been associated with noticeable symptom improvement within hours to days in many clinical observations. This rapid onset may be particularly valuable for patients experiencing severe depressive episodes or those for whom prolonged waiting periods pose a clinical concern.
Intravenous Delivery and Bioavailability
When ketamine is administered intravenously, it enters the bloodstream directly, allowing for near-complete bioavailability. This means the clinician can precisely control the dosage delivered to the patient throughout the infusion. At Healing and Psychiatry in Flagstaff, each IV Ketamine session is conducted under careful medical supervision, with dosing tailored to the individual patient’s needs and monitored in real time for both safety and comfort.
Efficacy Comparison: Spravato vs. IV Ketamine for Depression
One of the most common questions patients ask when exploring ketamine-based treatments is how IV Ketamine and Spravato (esketamine) compare. The efficacy comparison between Spravato and IV Ketamine for depression is nuanced and depends on several clinical and practical factors.
Formulation and Administration Differences
Spravato is an FDA-approved nasal spray that contains esketamine, the S-enantiomer of ketamine. It is administered in a certified healthcare setting under a Risk Evaluation and Mitigation Strategy (REMS) program. IV Ketamine, on the other hand, uses racemic ketamine – which contains both the S- and R-enantiomers – delivered directly into the bloodstream through an intravenous line. This difference in formulation and delivery method influences how the medication is absorbed, how dosing is managed, and how patients may respond.
Dosing Precision and Customization
A notable advantage of IV Ketamine in the efficacy comparison of Spravato vs. IV Ketamine for depression is the degree of dosing flexibility it allows. Because the medication is delivered intravenously, providers can make real-time adjustments during the infusion based on how the patient is responding. Spravato, by contrast, is available in fixed-dose nasal spray devices (56 mg and 84 mg), which limits the ability to fine-tune the dose mid-session. For patients who may benefit from individualized dosing protocols, IV Ketamine offers a level of clinical customization that nasal spray delivery does not readily accommodate.
Bioavailability Considerations
IV Ketamine achieves approximately 100% bioavailability because it bypasses the digestive system and nasal mucosa entirely. Spravato’s intranasal delivery results in variable absorption that can be influenced by nasal congestion, sinus conditions, or individual anatomical differences. While both treatments have demonstrated therapeutic potential in clinical literature, the consistently high bioavailability of IV Ketamine is one factor that clinicians may weigh when selecting the most appropriate treatment approach for a given patient.
Clinical Evidence and Emerging Research
Both IV Ketamine and Spravato have accumulated a growing body of clinical evidence supporting their use for treatment-resistant depression. Spravato received FDA approval in 2019 for TRD when used in conjunction with an oral antidepressant. IV Ketamine, while used off-label for depression, has been studied extensively in clinical trials and academic research since the early 2000s. As of 2026, ongoing studies continue to refine our understanding of optimal protocols, long-term outcomes, and patient selection criteria for both modalities. Patients interested in the efficacy comparison of Spravato vs. IV Ketamine for depression are encouraged to discuss their individual clinical history with a qualified provider to determine which option may be most appropriate.
Key Benefits of IV Ketamine Therapy at Healing and Psychiatry
At Healing and Psychiatry in Flagstaff, AZ, IV Ketamine therapy is delivered with a focus on patient safety, clinical precision, and individualized care. Below are several of the key benefits that patients may experience when pursuing this treatment.
Personalized Treatment Protocols
Every patient’s experience with depression is unique, and treatment should reflect that. The clinical team at Healing and Psychiatry develops individualized IV Ketamine protocols based on each patient’s medical history, symptom severity, prior treatment responses, and overall health profile. This tailored approach helps ensure that each infusion is optimized for the individual rather than relying on a one-size-fits-all model.
Potential for Rapid Symptom Relief
Many patients who undergo IV Ketamine therapy report experiencing a reduction in depressive symptoms more quickly than they have with previous treatments. While results vary and are not guaranteed, the potential for faster-acting relief is one of the most frequently cited benefits in both clinical literature and patient accounts. For individuals who have been living with persistent depression for months or years, even a modest improvement in a shorter time frame can be meaningful.
Supervised Clinical Environment
Each IV Ketamine infusion at Healing and Psychiatry takes place in a controlled clinical setting under the direct supervision of trained medical professionals. Vital signs are monitored throughout the session, and the clinical team is available to address any questions or concerns in real time. This supervised environment helps maximize both safety and patient comfort during the treatment process.
A Complement to Comprehensive Mental Health Care
IV Ketamine therapy is most effective when integrated into a broader mental health treatment plan. At Healing and Psychiatry, patients are encouraged to continue working with their existing mental health providers, therapists, and support systems alongside their IV Ketamine sessions. This integrative approach recognizes that lasting improvement in depression often requires a multifaceted strategy rather than a single intervention.
What to Expect During IV Ketamine Treatment
For patients in Flagstaff and the surrounding Northern Arizona area who are considering IV Ketamine therapy, understanding what to expect can help ease any uncertainty about the process.
Initial Consultation
Treatment at Healing and Psychiatry begins with a thorough consultation to evaluate whether IV Ketamine is a suitable option. This includes a review of the patient’s psychiatric history, current medications, medical conditions, and treatment goals. This step is essential for developing a safe and effective treatment plan.
The Infusion Process
A typical IV Ketamine infusion session lasts approximately 40 to 60 minutes, during which the patient reclines comfortably while the medication is administered through an IV line. Most initial treatment courses involve a series of infusions scheduled over two to three weeks, though the exact protocol will depend on the patient’s individual needs and response. Patients should plan for a brief observation period following each session before being released.
Post-Treatment and Ongoing Care
After the initial series of infusions, many patients transition to a maintenance schedule that may include periodic booster sessions. The frequency and duration of maintenance treatment vary based on how each patient responds. Throughout the process, the team at Healing and Psychiatry works closely with patients to monitor progress, adjust protocols as needed, and coordinate care with other treating providers.
Is IV Ketamine Therapy Right for You?
IV Ketamine therapy may be a suitable option for individuals who have not found adequate relief from traditional antidepressant medications and psychotherapy. It is not appropriate for everyone, and candidacy depends on a range of medical and psychiatric factors that should be evaluated by a qualified clinician. The efficacy comparison between Spravato and IV Ketamine for depression is an important consideration in this decision, and the providers at Healing and Psychiatry can help patients understand the differences and determine which approach may best align with their clinical needs.
If you or a loved one in Flagstaff, AZ, is living with treatment-resistant depression and exploring advanced treatment options, Healing and Psychiatry is here to help. We encourage you to reach out to our clinic to schedule a consultation and learn more about whether IV Ketamine therapy may be an appropriate step in your mental health care journey. Contact Healing and Psychiatry today to begin the conversation.